M
Midwest Allergy Sinus Asthma, SC | Normal, IL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
PF-04965842
Ruxolitinib
PF04965842
MK-7264-027
MK-7264
Dupilumab
Povorcitinib
Gefapixant
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 7 total trials
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems